The Curbsiders Internal Medicine Podcast
Aug 24, 2026 · 1 hr 19 min · 18 segments
I’m Going Bananas for This One! Learn how to formulate a framework while dealing with potassium disorders in patients with varying levels of kidney disease.We’re joined by Dr Joel Topf…
Paul WilliamsHost
Sai AchiHostSo with, with hyperkalemia, so in patients, uh, and, and this episode, this was great because we did a previous hyperkalemia episode, like, in 2017 that was really focused on the acute management and, uh, and inpatient management.
So for all new interns that are listening to this, go find that old episode of hyperkalemia.
This episode is much more focused on, hey, you're in clinic and you got a patient with mild hyperkalemia.
We talked about, uh, the lack of a relationship between dietary potassium, so don't spend a lot of time focusing on dietary advice.
You're gonna really go off in the wrong direction, and that we're gonna focus on, we went through a, a good list of the medications that cause hyperkalemia and how to think about those medications.
And then, uh, in terms of management, uh, you know, don't sleep on your diuretics.
Go ahead and treat their metabolic alkalosis with some sodium bicarb- excuse me.
When it came to hypokalemia, we talked about, uh, uh, whether that can be, uh, renal losses or extrarenal losses, and that, uh, we talked about, um, magnesium as being an important component in that and the proton pump inhibitors being involved there.
Before that, we also went in and we talked about the potassium switch, which I just need to talk about 'cause I think it's so darn cool, and this potassium switch is new physiology that we've discovered where it's, uh, the kidney just not leaving anything to chance, taking care of that potassium.
That increased potassium intake has a thiazide-like effect, which is gonna cause increased potassium excretion and increased sodium excretion, so you'll get some hypotensive effect, and that that was put into action in the SASS trial in rural China where we were able to reduce not only stroke but total mortality by giving patients additional potassium chloride.
And then lastly, we finished off in the dialysis unit where you should always finish off your dialysis in the d- uh, always finish off your rounds in the dialysis unit, and we talked about using some of the new potassium binders in novel ways to treat, uh, uh, dialysis patients.
So with, with hyperkalemia, so in patients, uh, and, and this episode, this was great because we did a previous hyperkalemia episode, like, in 2017 that was really focused on the acute management and, uh, and inpatient management.
So for all new interns that are listening to this, go find that old episode of hyperkalemia.
This episode is much more focused on, hey, you're in clinic and you got a patient with mild hyperkalemia.
We talked about, uh, the lack of a relationship between dietary potassium, so don't spend a lot of time focusing on dietary advice.
You're gonna really go off in the wrong direction, and that we're gonna focus on, we went through a, a good list of the medications that cause hyperkalemia and how to think about those medications.
And then, uh, in terms of management, uh, you know, don't sleep on your diuretics.
Go ahead and treat their metabolic alkalosis with some sodium bicarb- excuse me.
When it came to hypokalemia, we talked about, uh, uh, whether that can be, uh, renal losses or extrarenal losses, and that, uh, we talked about, um, magnesium as being an important component in that and the proton pump inhibitors being involved there.
Before that, we also went in and we talked about the potassium switch, which I just need to talk about 'cause I think it's so darn cool, and this potassium switch is new physiology that we've discovered where it's, uh, the kidney just not leaving anything to chance, taking care of that potassium.
That increased potassium intake has a thiazide-like effect, which is gonna cause increased potassium excretion and increased sodium excretion, so you'll get some hypotensive effect, and that that was put into action in the SASS trial in rural China where we were able to reduce not only stroke but total mortality by giving patients additional potassium chloride.
And then lastly, we finished off in the dialysis unit where you should always finish off your dialysis in the d- uh, always finish off your rounds in the dialysis unit, and we talked about using some of the new potassium binders in novel ways to treat, uh, uh, dialysis patients.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.